About
Technology
Issues
FAQ
Links
Official Page
A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.